Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa
- Price, Joan T.
- Wheeler, Stephanie B.
- Stranix-Chibanda, Lynda
- Hosek, Sybil G.
- Heather Watts,
- Siberry, George K.
- Spiegel, Hans M. L.
- Stringer, Jeffrey S.
- Chi, Benjamin H.
DOIAbstract
Antiretroviral pre-exposure prophylaxis (PrEP) for the prevention of HIV acquisition is cost-effective when delivered to those at substantial risk. Despite a high incidence of HIV infection among pregnant and breastfeeding women in sub-Saharan Africa (SSA), a theoretical increased risk of preterm birth on PrEP could outweigh the HIV prevention benefit
Add to ORKG